Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Compugen (CGEN) Shares Outstanding (2016 - 2025)

Compugen's Shares Outstanding history spans 17 years, with the latest figure at $94.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 5.6% to $94.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $94.6 million, a 5.6% increase, with the full-year FY2025 number at $94.6 million, up 5.6% from a year prior.
  • Shares Outstanding hit $94.6 million in Q4 2025 for Compugen, up from $89.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CGEN hit a ceiling of $94.6 million in Q4 2025 and a floor of $86.4 million in Q4 2021.
  • Historically, Shares Outstanding has averaged $89.3 million across 5 years, with a median of $89.2 million in 2023.
  • Biggest five-year swings in Shares Outstanding: rose 0.22% in 2022 and later rose 5.6% in 2025.
  • Tracing CGEN's Shares Outstanding over 5 years: stood at $86.4 million in 2021, then increased by 0.22% to $86.6 million in 2022, then increased by 3.02% to $89.2 million in 2023, then rose by 0.34% to $89.5 million in 2024, then grew by 5.6% to $94.6 million in 2025.
  • Business Quant data shows Shares Outstanding for CGEN at $94.6 million in Q4 2025, $89.5 million in Q4 2024, and $89.2 million in Q4 2023.